Conditions: Epistaxis; Blood Pressure
Interventions: Drug: Oxymetazoline 0.05%; Drug: Phenylephrine 0.25%; Drug: Lidocaine 1% plus epinephrine 1:100,000; Drug: Bacteriostatic 0.9% NaCL
Sponsor: Mayo Clinic
Recruiting – verified November 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days